WO2000012760A3 - Toxicological response markers - Google Patents
Toxicological response markers Download PDFInfo
- Publication number
- WO2000012760A3 WO2000012760A3 PCT/US1999/019768 US9919768W WO0012760A3 WO 2000012760 A3 WO2000012760 A3 WO 2000012760A3 US 9919768 W US9919768 W US 9919768W WO 0012760 A3 WO0012760 A3 WO 0012760A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- response markers
- toxicological response
- composition
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002340589A CA2340589A1 (en) | 1998-08-28 | 1999-08-27 | Toxicological response markers |
JP2000567743A JP2002523112A (en) | 1998-08-28 | 1999-08-27 | Toxicological markers |
AU60222/99A AU6022299A (en) | 1998-08-28 | 1999-08-27 | Toxicological response markers |
EP99968250A EP1108067A2 (en) | 1998-08-28 | 1999-08-27 | Toxicological response markers |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/141,825 US6403778B1 (en) | 1998-05-04 | 1998-08-28 | Toxicological response markers |
US09/141,825 | 1998-08-28 | ||
US09/172,711 | 1998-10-13 | ||
US09/172,108 US6160104A (en) | 1998-10-13 | 1998-10-13 | Markers for peroxisomal proliferators |
US09/172,108 | 1998-10-13 | ||
US09/172,711 US6160105A (en) | 1998-10-13 | 1998-10-13 | Monitoring toxicological responses |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000012760A2 WO2000012760A2 (en) | 2000-03-09 |
WO2000012760A3 true WO2000012760A3 (en) | 2000-08-03 |
Family
ID=27385714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/019768 WO2000012760A2 (en) | 1998-08-28 | 1999-08-27 | Toxicological response markers |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1108067A2 (en) |
JP (1) | JP2002523112A (en) |
AU (1) | AU6022299A (en) |
CA (1) | CA2340589A1 (en) |
WO (1) | WO2000012760A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6881571B1 (en) | 1998-03-11 | 2005-04-19 | Exonhit Therapeutics S.A. | Qualitative differential screening |
FR2798392B1 (en) * | 1999-09-13 | 2005-07-15 | Exonhit Therapeutics Sa | GENETIC MARKERS OF TOXICITY, PREPARATION AND USES |
WO2002008453A2 (en) * | 2000-07-21 | 2002-01-31 | Phase-1 Molecular Toxicology | Canine toxicity genes |
AU2001280889A1 (en) * | 2000-07-31 | 2002-02-13 | Gene Logic, Inc. | Molecular toxicology modeling |
US7590493B2 (en) | 2000-07-31 | 2009-09-15 | Ocimum Biosolutions, Inc. | Methods for determining hepatotoxins |
EP1368499A2 (en) * | 2001-01-29 | 2003-12-10 | Phase-1 Molecular Toxicology Inc. | Rat toxicologically relevant genes and uses thereof |
US7415358B2 (en) | 2001-05-22 | 2008-08-19 | Ocimum Biosolutions, Inc. | Molecular toxicology modeling |
US7447594B2 (en) | 2001-07-10 | 2008-11-04 | Ocimum Biosolutions, Inc. | Molecular cardiotoxicology modeling |
US20040241690A1 (en) * | 2001-08-03 | 2004-12-02 | Takayuki Souka | Method of evaluating biocompatibility |
JP4836403B2 (en) * | 2001-08-24 | 2011-12-14 | 独立行政法人産業技術総合研究所 | Method for detecting toxic substances |
US7469185B2 (en) | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
EP1344834A3 (en) * | 2002-03-14 | 2004-06-02 | F. Hoffmann-La Roche Ag | Methods for the toxicity prediction of a compound |
GB0215509D0 (en) * | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
WO2004058957A2 (en) * | 2002-12-31 | 2004-07-15 | Pharmacia & Upjohn Company Llc | Canine cyp1a2 sequences |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995020681A1 (en) * | 1994-01-27 | 1995-08-03 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
WO1997013877A1 (en) * | 1995-10-12 | 1997-04-17 | Lynx Therapeutics, Inc. | Measurement of gene expression profiles in toxicity determination |
-
1999
- 1999-08-27 WO PCT/US1999/019768 patent/WO2000012760A2/en not_active Application Discontinuation
- 1999-08-27 JP JP2000567743A patent/JP2002523112A/en active Pending
- 1999-08-27 EP EP99968250A patent/EP1108067A2/en not_active Withdrawn
- 1999-08-27 AU AU60222/99A patent/AU6022299A/en not_active Abandoned
- 1999-08-27 CA CA002340589A patent/CA2340589A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995020681A1 (en) * | 1994-01-27 | 1995-08-03 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
WO1997013877A1 (en) * | 1995-10-12 | 1997-04-17 | Lynx Therapeutics, Inc. | Measurement of gene expression profiles in toxicity determination |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL embl heidelberg; 30 September 1995 (1995-09-30), LEE H.N. ET AL.,: "EST108960 rat PC-12 cells", XP002130308 * |
LEE N.H. ET AL.,: "Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment", PROC. NATL. ACAD. SCI. USA, vol. 92, - August 1995 (1995-08-01), pages 8303 - 8307, XP002047703 * |
SCHENA M ET AL: "PARALLEL HUMAN GENOME ANALYSIS: MICROARRAY-BASED EXPRESSION MONITORING OF 1000 GENES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 93, no. 20, 1 October 1996 (1996-10-01), pages 10614 - 10619, XP002912238, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
EP1108067A2 (en) | 2001-06-20 |
AU6022299A (en) | 2000-03-21 |
JP2002523112A (en) | 2002-07-30 |
CA2340589A1 (en) | 2000-03-09 |
WO2000012760A2 (en) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001036684A3 (en) | Mammalian toxicological response markers | |
WO2000012760A3 (en) | Toxicological response markers | |
AU2001245945A1 (en) | Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof | |
AU2003228649A1 (en) | Compositions and methods related to two-arm nucleic acid probes | |
GB9926733D0 (en) | Analysis of single nucleotide polymorphisms using mass spectrometry | |
CA2311182A1 (en) | Transcription factor decoy and tumor growth inhibitor | |
CA2412967A1 (en) | Sequencing method | |
WO2002038806A3 (en) | Detection of nucleic acid polymorphisms | |
IL154689A0 (en) | Compositions containing nucleic acid primers or constructs and methods for detecting nucleic acids using the same | |
WO1999067619A3 (en) | Compounds and methods for detecting biomolecules | |
WO2003064625A3 (en) | Oligonucleotide compositions with enhanced efficiency | |
HUP0103414A3 (en) | Nucleic acid molecules encoding an amylosucrase | |
DE69808274D1 (en) | COMBINATION PRODUCT CONTAINING A NUCLEIC ACID AND A SUBSTANCE THAT DISORGANIZES THE EXTRACELLULAR MATRIX FOR USE IN GENE THERAPY | |
WO2003064605A3 (en) | Crude biological derivatives competent for nucleic acid detection | |
WO2006017549A3 (en) | Cell-based kinase assay | |
NO982176L (en) | Corrosion Inhibited Organic Acid Compositions and Methods for Using Them | |
WO2004003220A3 (en) | Methods and composition for analyzing compromised samples using snps | |
Stenersen et al. | Earthworms for toxicity testing; species differences in response towards cholinesterase inhibiting insecticides | |
WO2002002740A3 (en) | Methods and compositions for determining gene function | |
AU2003244370A1 (en) | Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing | |
EP1573037A3 (en) | Methods and compositions for analyzing compromised samples using single nucleotide polymorphism panels | |
WO1999055913A3 (en) | Reduced complexity nucleic acid targets and methods of using same | |
AU4854999A (en) | Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule | |
AU2002361146A1 (en) | Normalisation of microarray data based on hybridisation with an internal reference | |
SG148027A1 (en) | Methods for identifying combinations of entities as therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2340589 Country of ref document: CA Ref country code: CA Ref document number: 2340589 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 567743 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999968250 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999968250 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999968250 Country of ref document: EP |